News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,298 Results
Type
Article (42600)
Company Profile (281)
Press Release (694405)
Multimedia
Podcasts (97)
Webinars (20)
Section
Business (206050)
Career Advice (2051)
Deals (35760)
Drug Delivery (133)
Drug Development (81871)
Employer Resources (173)
FDA (16555)
Job Trends (15038)
News (348556)
Policy (32877)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2659)
Accelerated approval (52)
Adcomms (27)
Allergies (175)
Alliances (50102)
ALS (219)
Alzheimer's disease (1817)
Antibody-drug conjugate (ADC) (489)
Approvals (16972)
Artificial intelligence (695)
Autoimmune disease (314)
Automation (59)
Bankruptcy (364)
Best Places to Work (11674)
BIOSECURE Act (21)
Biosimilars (224)
Biotechnology (184)
Bladder cancer (200)
Brain cancer (75)
Breast cancer (790)
Cancer (6113)
Cardiovascular disease (486)
Career advice (1742)
Career pathing (43)
CAR-T (347)
CDC (58)
Celiac Disease (3)
Cell therapy (936)
Cervical cancer (51)
Clinical research (71350)
Collaboration (2131)
Company closure (5)
Compensation (1438)
Complete response letters (82)
COVID-19 (2770)
CRISPR (115)
C-suite (1182)
Cystic fibrosis (155)
Data (8302)
Decentralized trials (3)
Denatured (30)
Depression (166)
Dermatology (92)
Diabetes (608)
Diagnostics (7072)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (335)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92331)
Editorial (67)
Employer branding (21)
Employer resources (152)
Events (120777)
Executive appointments (1104)
FDA (20390)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1773)
Gene editing (250)
Generative AI (57)
Gene therapy (743)
GLP-1 (1071)
Government (4764)
Grass and pollen (6)
Guidances (414)
Healthcare (19211)
HIV (83)
Huntington's disease (58)
IgA nephropathy (105)
Immunology and inflammation (294)
Immuno-oncology (99)
Indications (201)
Infectious disease (3123)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (302)
Interviews (321)
IPO (16739)
IRA (50)
Job creations (3665)
Job search strategy (1445)
JPM (59)
Kidney cancer (19)
Labor market (105)
Layoffs (573)
Leadership (40)
Legal (7973)
Liver cancer (103)
Longevity (34)
Lung cancer (819)
Lymphoma (444)
Machine learning (61)
Management (59)
Manufacturing (1083)
MASH (200)
Medical device (14039)
Medtech (14176)
Mergers & acquisitions (20285)
Metabolic disorders (1554)
mRNA (224)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (437)
Neuropsychiatric disorders (107)
Neuroscience (3385)
Neurotech (1)
NextGen: Class of 2026 (6570)
Non-profit (4564)
Now hiring (79)
Obesity (722)
Opinion (296)
Ovarian cancer (234)
Pain (260)
Pancreatic cancer (329)
Parkinson's disease (375)
Partnered (33)
Patents (612)
Patient recruitment (699)
Peanut (64)
People (60119)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22292)
Phase 2 (31445)
Phase 3 (23372)
Pipeline (9255)
Policy (323)
Postmarket research (2571)
Preclinical (9490)
Press Release (65)
Prostate cancer (323)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1113)
Real estate (6010)
Recruiting (70)
Regulatory (25651)
Reports (56)
Research institute (2472)
Resumes & cover letters (356)
Rett syndrome (39)
RNA editing (24)
RSV (88)
Schizophrenia (181)
Series A (300)
Series B (217)
Service/supplier (11)
Sickle cell disease (120)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (49)
Startups (3687)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (65)
Vaccines (1126)
Venture capital (115)
Weight loss (463)
Women's health (130)
Worklife (20)
Date
Today (129)
Last 7 days (743)
Last 30 days (3414)
Last 365 days (30392)
2026 (14263)
2025 (30335)
2024 (35402)
2023 (40280)
2022 (51396)
2021 (55951)
2020 (54329)
2019 (46801)
2018 (35241)
2017 (32375)
2016 (31773)
2015 (37824)
2014 (31526)
2013 (26590)
2012 (28789)
2011 (29426)
2010 (27538)
Location
Africa (754)
Alabama (93)
Alaska (7)
Arizona (355)
Arkansas (14)
Asia (40272)
Australia (6587)
California (13679)
Canada (3853)
China (1420)
Colorado (583)
Connecticut (604)
Delaware (421)
Europe (87162)
Florida (2035)
Georgia (438)
Hawaii (3)
Idaho (63)
Illinois (1101)
India (92)
Indiana (617)
Iowa (24)
Japan (561)
Kansas (134)
Kentucky (51)
Louisiana (44)
Maine (76)
Maryland (1642)
Massachusetts (9809)
Michigan (370)
Minnesota (736)
Mississippi (6)
Missouri (147)
Montana (33)
Nebraska (29)
Nevada (146)
New Hampshire (85)
New Jersey (3572)
New Mexico (29)
New York (3576)
North Carolina (1742)
North Dakota (11)
Northern California (6873)
Ohio (410)
Oklahoma (24)
Oregon (41)
Pennsylvania (2735)
Puerto Rico (29)
Rhode Island (51)
South America (1121)
South Carolina (86)
South Dakota (2)
Southern California (5411)
Tennessee (218)
Texas (2182)
United States (48248)
Utah (407)
Vermont (1)
Virginia (330)
Washington D.C. (81)
Washington State (1091)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
737,298 Results for "c2i genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Veracyte Completes Acquisition of C2i Genomics
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform.
February 6, 2024
·
5 min read
Press Releases
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
·
5 min read
Press Releases
Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics
March 5, 2026
·
1 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics
April 20, 2026
·
5 min read
Business
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform.
January 8, 2024
·
9 min read
Press Releases
Genomic Testing Cooperative to Exhibit and Present Research at 2026 ASCO Annual Meeting
May 28, 2026
·
4 min read
Press Releases
10x Genomics Reports First Quarter 2026 Financial Results
May 8, 2026
·
9 min read
Press Releases
KROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World’s First Genomic Intelligence Platform
April 30, 2026
·
2 min read
Press Releases
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 18, 2025
·
6 min read
1 of 73,730
Next
